GlassScriptPhysician profile
Amy S Henson
NPI 1952556680
$9,054.32
in general payments reported to CMS, 2019-2025
49 companies · $1,984 in 2025
The $1,984 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,154 · 2022: $2,220 · 2023: $1,362 · 2024: $2,334 · 2025: $1,984.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,680.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $1,005.38 | 2022 | |
| Abbvie INC. | $938.98 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $800.67 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Amgen INC. | $774.80 | 2021-2025 | Repatha, Otezla, Repatha |
| Lilly USA, LLC | $633.58 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Novo Nordisk INC | $624.62 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $432.04 | 2023-2025 | |
| Abbott Laboratories | $336.70 | 2021-2025 | Freestyle Libre |
| Boehringer Ingelheim Pharmaceuticals, INC. | $281.76 | 2021-2025 | Jardiance |
| Dexcom, INC. | $269.00 | 2021-2024 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $232.03 | 2023-2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $208.89 | 2022-2024 | Austedo Xr, Austedo, Uzedy |
| Merck Sharp & Dohme LLC | $169.43 | 2021-2023 | Belsomra, Steglatro |
| Medtronic, INC. | $167.16 | 2023 | Corevalve Evolut R |
| Bayer Healthcare Pharmaceuticals INC. | $165.00 | 2022-2023 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Henson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.